Clinical Trials
86 trialsA Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
High-resolution Intra-operative PSMA PET-CT in Prostate Cancer
IRCCS San Raffaele
DARE
Bayer
TRAP-PAIN
Kayseri Education and Research Hospital
PROMET-BR
AstraZeneca
ProPCI
Radboud University Medical Center
FOLLOW-UP
Imperial College London
BALANCE
Institute of Cancer Research, United Kingdom
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Assiut University
Outcomes of Definitive Radiotherapy for Bladder Cancer
Sohag University
CHAS3
Insel Gruppe AG, University Hospital Bern
PULSE
Novartis
18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
Assiut University
RASROP-003
Humanitas Hospital, Italy
UroDNA
Institut Cancerologie de l'Ouest
PRIAPUS-PCa
CancerCare Manitoba
PROSTest_STRAT
Wren Laboratories LLC
VAPOR-LTR
Francis Medical Inc.
CLEAR-PC
Universidad Miguel Hernandez de Elche
TransPRIDE
Queen Mary University of London
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Mayo Clinic
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ARON-2PLUS
Aron Research Foundation Ets
SEQ-bpMRI
Peking University First Hospital
INCLUDE PC
Royal Marsden NHS Foundation Trust
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer
Anhui Medical University
AI for Renal Tumors Using Non-Contrast CT
Fudan University
SARC-NMIBC
General Hospital Sveti Duh
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Konkuk University Medical Center
NEUTROFLOW
OncoHost Ltd.
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
RWS-GU001
Shanghai Pudong New Area Gongli Hospital
γδ-T-BLADDER
Shanghai 10th People's Hospital
AssiutU
Assiut University
ultraHART
Jena University Hospital
A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics
Anhui Medical University
PREDICT
Gold Standard Phantoms
MASS-ADT
Guy's and St Thomas' NHS Foundation Trust
PROSPEX
Ankara University
Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy
National Taiwan University Hospital
LODE
Ente Ospedaliero Ospedali Galliera
RUPTURE
Azienda Ospedaliera Universitaria Integrata Verona
Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy
Peking University First Hospital
Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy
Peking University First Hospital
LOCUS
AstraZeneca
Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer
Nanfang Hospital, Southern Medical University